Syros pharmaceuticals yahoo finance

Author: zkbz

August undefined, 2024

WebSep 15, 2024 · In addition, Syros today announced that it will effect a 1-for-10 reverse stock split of its common stock that will be effective on Friday, September 16, 2024, prior to the closings of the Merger... WebGet the latest Syros Pharmaceuticals Inc (SYRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Can Syros Pharmaceuticals (SYRS) Run Higher on Strong Earnings …

WebSyros Pharmaceuticals Inc (SYRS) Stock Price & News - Google Finance 19.30 Home SYRS • NASDAQ Syros Pharmaceuticals Inc Follow Share $2.71 Mar 30, 2:59:38 PM GMT-4 · USD · NASDAQ ·... WebSep 16, 2024 · Shares of the combined company will trade on Nasdaq under the ticker symbol “SYRS.” Concurrent with the closing of the merger, Syros also closed the previously announced oversubscribed $130 million private investment in public equity (PIPE) financing. los angeles garfield football

Syros Pharmaceuticals, Inc. (SYRS) Stock Price, News

WebView the latest Syros Pharmaceuticals Inc. (SYRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebMar 8, 2024 · Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or monthly formats back to when Syros Pharmaceuticals, Inc. stock was issued. WebNov 12, 2024 · Syros Pharmaceuticals, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.56 million for the quarter ended September 2024, surpassing the Zacks... horizon typhon 4x4

SYRS Stock Forecast, Price & News (Syros Pharmaceuticals) - MarketB…

WebYahoo March 2, 2024 CAMBRIDGE, Mass., March 02, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter and full-year ended December 31, 2024 and provided a corporate update. WebNov 14, 2024 · CAMBRIDGE, Mass., November 14, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of … horizon \u0026 atmosphere landscapeWebSep 16, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of... horizon two players

"WebPreviously, Mr. Nelsen served on the boards of Juno Therapeutics from August 2013 to March 2024, Syros Pharmaceuticals from August 2012 to June 2024, Sienna Biopharmaceuticals from August 2015 to October 2024, Agios Pharmaceuticals from December 2007 to June 2024, KYTHERA Biopharmaceuticals from January 2006 to … " - Syros pharmaceuticals yahoo finance

Syros pharmaceuticals yahoo finance

Syros Announces Closing of Merger with Tyme Technologies and …

WebJul 5, 2024 · (RTTNews) - Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire... WebJun 27, 2024 · Nancy Simonian has been the CEO of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) since 2012. First, this article will...

Did you know?

WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues … WebSyros Pharmaceuticals, Inc. (SYRS) Analyst Ratings, Estimates & Forecasts - Yahoo Finance S&P/TSX 19,501.49 +41.59(+0.21%) S&P 500 3,970.99 +22.27(+0.56%) DOW 32,237.53 …

WebMar 31, 2024 · Meanwhile, Syros Pharmaceuticals’ current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $2.57 per share 30 days ago to $2.32 per share today, an increase of 9.7%.

WebMar 31, 2024 · Meanwhile, Syros Pharmaceuticals’ current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none … WebSep 23, 2024 · Syros Pharmaceuticals, Inc. (SYRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might …

WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies...

WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead... los angeles gas users tax renewalWebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues … horizon twoWebSep 20, 2024 · Syros Pharmaceuticals has recently acquired its peer Tyme Technologies. The sole purpose of the merger was to acquire TYME's cash balance. Concurrently with the merger, the largest shareholders... los angeles garden tours 2016 californiaWebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues … horizon two sixWebNov 14, 2024 · CAMBRIDGE, Mass., November 14, 2024 -- ( BUSINESS WIRE )--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported... horizon typefaceWebSyros Pharmaceuticals, Inc. (SYRS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Add to watchlist 2.6700 -0.0500 (-1.84%) At close: 04:00PM EDT 2.7900 +0.12 … los angeles gas company loginWebApr 12, 2024 · Syros Pharmaceuticals - SYRS Stock Forecast, Price & News $2.56 +0.05 (+1.99%) (As of 04/10/2024 02:13 PM ET) Compare Today's Range $2.52 $2.58 50-Day … horizon \u0026 atmosphere landscape co